August 10, 2021 - August 12, 2021

Chemplast Sanmar IPO Review & Recommendations

Dilip Davda has given "May Apply" recommendation to Chemplast Sanmar IPO. Axis Capital and Edelweiss Broking Ltd have "Neutral" view about the IPO. Capital Market and InvestorGain.com recommend to "Avoid" the IPO.

Chemplast Sanmar IPO Review Summary from brokers and analysts

Review By	Apply	May Apply	Neutral	Avoid	Not Rated
Count	0	1	2	2	0
%	0.00	20.00	40.00	40.00	0.00

Chemplast Sanmar IPO Analysis By Brokers/Analysts

Reviewer	Recommendation	Past Reviews
Axis Capital	Neutral
Capital Market	Avoid
Dilip Davda	May Apply
Edelweiss Broking Ltd	Neutral
InvestorGain.com	Avoid

Chemplast Sanmar IPO Capital Market Rating

The Captial Market (CapitalMarket.com) rating for Chemplast Sanmar IPO is 38. Their analysis recommends Do not subscribe for the IPO.

Reviewer	Rating Score	Rating
Capital Market	38	Do not subscribe

Chemplast Sanmar IPO Review by Dilip Davda (May apply)

[Dilip Davda] After a decade the company is trying to relist its shares with 7.5 times higher valuations. It has done many juggleries in the account as can be seen from frequent changes in the Face Value (FV) of its equity shares. Though the issue appears reasonably priced, it is due to the non-convincing super performance of FY21 and sustainability is a major concern. Hence cash surplus/risk seekers may consider investment, others can ignore it. Read detail review...

Post Recommendation Manage Recommendations

Note:

The recommendations or analysis of public issues posted above expresses the views of its author and does not represent the views of Chittorgarh.com or its staff.
We reserve the right to remove any objectionable post without providing a reason.